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Abstract
The global prevalence of Fe deficiency is high and a common corrective strategy is oral Fe supplementation, which may affect the
commensal gut microbiota and gastrointestinal health. The aim of the present study was to investigate the impact of different dietary
Fe concentrations on the gut microbiota and gut health of rats inoculated with human faecal microbiota. Rats (8 weeks old, n 40) were
divided into five (n 8 each) groups and fed diets differing only in Fe concentration during an Fe-depletion period (12 weeks) and an
Fe-repletion period (4 weeks) as follows: (1) Fe-sufficient diet throughout the study period; (2) Fe-sufficient diet followed by 70 mg
Fe/kg diet; (3) Fe-depleted diet throughout the study period; (4) Fe-depleted diet followed by 35 mg Fe/kg diet; (5) Fe-depleted diet
followed by 70 mg Fe/kg diet. Faecal and caecal samples were analysed for gut microbiota composition (quantitative PCR and pyrosequen-
cing) and bacterial metabolites (HPLC), and intestinal tissue samples were investigated histologically. Fe depletion did not significantly alter
dominant populations of the gut microbiota and did not induce Fe-deficiency anaemia in the studied rats. Provision of the 35 mg Fe/kg diet
after feeding an Fe-deficient diet significantly increased the abundance of dominant bacterial groups such as Bacteroides spp. and
Clostridium cluster IV members compared with that of an Fe-deficient diet. Fe supplementation increased gut microbial butyrate concen-
tration 6-fold compared with Fe depletion and did not affect histological colitis scores. The present results suggest that Fe supplementation
enhances the concentration of beneficial gut microbiota metabolites and thus may contribute to gut health.
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Research carried out in the past few years has highlighted the
importance of the gut microbiota to intestinal health and host
health in general(1,2). The gut microbiota plays a crucial role in
the development and maintenance of the immune system(3),
colonisation resistance to environmental bacteria, such as
pathogens(4), extraction of energy from indigestible food com-
ponents and production of metabolites that influence gut
health(5). SCFA have been widely investigated due to their
ability to influence several aspects of host health. Many mem-
bers of the gut microbiota produce acetate and propionate.
Acetate is either reused by other bacteria for butyrate for-
mation or absorbed by the host and can be used as an
energy source, while propionate is involved in gluconeo-
genesis(6,7). The most investigated end metabolite of the gut
microbiota is probably butyrate due to its importance to
mucosal health. Butyrate is mainly produced by the members
of Clostridium clusters IV and XIVa, such as Faecalibacterium
prausnitzii, Eubacterium hallii and Roseburia spp.,(8,9) and is
absorbed by the mucosa where it can act as an energy source
for colonocytes(10). Moreover, butyrate has anti-inflammatory
effects, is able to promote apoptosis in cancer cells and has
been shown to inhibit virulence in enteropathogens(11,12).
Gut microbiota composition and metabolic activity not
only affect the host but are also strongly modified by host
and environmental factors. Diet composition, such as fibre
content, has been shown to have a strong impact on the
gut microbiota(13,14). Recent studies have elucidated the
differences in gut microbial consortium in populations living
in developed and developing countries possibly due to
the effects of diet or high prevalence of malnutrition in
developing countries, which can strongly influence the gut
microbiota(3,15–20). One of the most common nutritional
deficiencies is Fe deficiency, affecting more than two billion
people worldwide, especially in developing countries(21,22).
*Corresponding author: C. Lacroix, fax þ41 44 632 14 03, email christophe.lacroix@hest.ethz.ch
Abbreviations: qPCR, quantitative PCR; SRB, sulphate-reducing bacteria.
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Fe deficiency affects cognitive and motor development in
children and increases the maternal/perinatal mortality
rate(23). It also has an impact on gut microbiota composition
and metabolic activity. In a recent rat study, we have shown
a decrease in the abundance of Roseburia spp./Eubacterium
rectale and Bacteroides spp. along with a large decrease
in the concentrations of caecal butyrate and propionate in
highly Fe-deficient young rats(24). Earlier studies in mice
have also demonstrated that low gut luminal Fe concentrations
have an impact on gut microbiota composition leading to a
decrease in the abundance of Desulfovibrio spp. and an
increase in that of Turicibacter spp.(25) while elevating the
counts of lactobacilli(26). Using an in vitro colonic fermen-
tation model mimicking the proximal colon of a child, we
have also confirmed strong dysbiosis of the gut microbiota
under very-low-Fe conditions(27).
Usual strategies for Fe-deficiency anaemia correction are
Fe supplementation and Fe fortification of foods; FeSO4 is
often used, which is highly bioavailable(28). However, absorp-
tion of Fe is usually low (5–20 %) and takes place mainly in
the duodenum, while the main fraction of Fe reaches the
colon, where it might affect the gut microbiota(21). Indeed,
gut microbiota composition in Fe-deficient rats supplemented
with Fe has been found to be partially recovered and gut
microbiota metabolic activity to be strongly promoted(24).
Animal studies in rats and pigs have also reported dysbiosis
of the gut microbiota due to Fe supplementation(26,29),
recently confirmed in human studies. School children in
Coˆte d’Ivoire have been found to have higher numbers
of Enterobacteriaceae and decreased numbers of lacto-
bacilli in faeces after Fe supplementation for 6 months and
increased concentrations of calprotectin, a marker for gut
inflammation (30). Infants given an Fe-supplemented diet for
3 months have been found to have higher relative abundances
of Bacteroides spp. and lower abundances of lactobacilli(31).
An unanswered question raised by these studies is whether
dietary Fe alone is a modulation factor for the gut microbiota
and intestinal inflammation or whether Fe status and suscepti-
bility to gut inflammation could also play a role in the
observed changes in gut microbiota composition. Both
changes in host Fe homeostasis and gut inflammation can
alter the gut microbiota composition(32–34). Our previous
study using Sprague–Dawley rats with a rodent microbiota
has investigated the changes in gut microbiota composition
due to Fe supplementation in a highly Fe-deficient host(24).
As the rodent microbiota differs from the human
microbiota(35–37), in the present study, we used gnotobiotic
rats associated with child microbiota, which represent an
excellent model to study host–microbiota interactions in a
well-controlled environment without confounding factors
such as variations in diet or host genetic background(38–40).
A child was selected as the faecal donor due to the high preva-
lence of Fe deficiency and need for Fe supplementation in this
age group(22,41). The human microbiota-associated rats were
fed diets differing in Fe concentration and source according
to the standard Fe depletion–repletion study used to assess
Fe bioavailability(42). Changes in faecal microbiota compo-
sition were analysed during the study period, and caecal
microbiota composition and metabolic activity, as well as
gut inflammation, were assessed after killing the rats at the
end of the study.
Materials and methods
Rats and diets
A total of forty germ-free female Fischer 344 rats were bred
at the INRA facilities of Clermont-Ferrand-Theix, France.
They were kept in sterile isolators with positive pressure
over the entire trial period as described previously(40,43).
Rats were fed an irradiated standard diet for germ-free rodents
(SAFE) and given free access to sterilised water. Rats were
maintained pairwise in standard Macrolon cages under a
12 h light–12 h dark cycle under constant temperature and
humidity. At 5 weeks of age, rats were inoculated with a
human faecal microbiota slurry obtained from a healthy volun-
teer (age 6 years) not treated with antibiotics 3 months before
faecal sample collection. The faecal sample was processed
within 6 h of defecation and maintained under anaerobic
conditions. After 1000-fold dilution with an anaerobic mineral
solution, 1 ml of faecal slurry was orally inoculated into germ-
free rats. The microbiota was allowed to establish for 3 weeks
while the rats were being fed a control diet with normal Fe
concentrations equivalent to a standardised American Institute
of Nutrition (AIN)-93G purified diet(44) before starting the
different feeding regimens.
All diets were produced by Dyets Inc. and based on a
standard AIN-93G diet differing only in Fe concentration
(Table S1, available online). The study set-up (Fig. 1) was
designed according to the classical Fe depletion–repletion
assay of Forbes et al.(42) and comprised five different groups
of rats. A ‘control’ group of rats (n 8) was fed a regular AIN-
93G diet containing a mean of 37·6 (SEM 0·9) mg Fe/kg diet
from ferric citrate over the entire trial period of 16 weeks,
while a ‘Fe-deficient’ group of rats (n 8) was fed an Fe-deficient
diet containing 2·9 (SEM 0·2) mg Fe/kg diet. A further two groups
of rats, ‘35 ppm Fe’ group (n 8) and ‘70 ppm Fe’ group (n 8),
were first fed a Fe-deficient diet for 12 weeks and were then
supplemented with either a 35 ppm Fe diet containing 32·2
(SEM 1·0) mg Fe/kg diet from FeSO4 or a 70 ppm Fe diet contain-
ing 66·1 (SEM 7·8) mg Fe/kg diet from FeSO4 and ferric citrate to
mimic Fe supplementation with two different Fe sources and
concentrations for 4 weeks. A fifth group of rats, ‘Fe-excess’
group (n 8), was first fed the control diet and was then sup-
plemented with the 70 ppm Fe diet to mimic the impact of Fe
supplementation on the gut microbiota not previously affected
by a low-Fe diet and to investigate the effects of excess Fe on the
gut microbiota. Once a week, body weight of each rat was
measured and diet intake was assessed cage-wise (two rats). Fe
concentration in the diets was assessed by atomic absorption
spectrometry (SpectrAA-240K with GTA-120 Graphite Tube Ato-
mizer, Varion Techtron) shortly before use. All procedures were
carried out according to the European Directives on
the protection of animals used for scientific purposes, 2010/63/
EU, and the laboratory procedures were approved by the local
ethics committee (CEMEAA 02).
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Sample collection
Faecal samples and blood samples of all rats were collected at
baseline (week 3), after the first feeding period at midpoint
(week 15) and at endpoint (week 19). Faecal samples were
frozen at 2808C until gut microbiota composition analysis
by quantitative PCR (qPCR). Fe concentration in the faecal
samples of the 35 ppm Fe-supplemented group, Fe-deficient
group and control group at endpoint (week 19) was assessed
by atomic absorption spectrometry (SpectrAA-240K with GTA-
120 Graphite Tube Atomizer, Varion Techtron). Blood samples
were collected by the tail vein clip method(45) and analysed
immediately for Hb concentrations using a Hemocue 201 instru-
ment (HemoCue). After killing the rats by CO2 inhalation, blood
was collected again by cardiac puncture and centrifuged
immediately, and serum was kept at 2808C until ferritin
measurements. Serum ferritin concentrations were assessed in
duplicate using a rat ferritin ELISA kit according to the manu-
facturer’s instructions (Immunology Consultants Laboratory, Inc.).
Sections of the ileum, caecum and colon were removed,
rinsed in PBS and immersed in 4 % paraformaldehyde, and
stored at 48C until histological analyses. Caecal contents were
also collected and frozen immediately at 2808C for caecal
microbiota metabolic activity and composition analyses.
Histological analyses of ileal, caecal and
colonic tissue samples
All histological analyses were carried out by the Histology
Analysis Platform of the Nantes Atlantic National College of
Veterinary Medicine, Food Science and Engineering (Oniris,
Nantes, France). After sectioning, ileal, caecal and colonic
tissue samples were stained with haematoxylin–eosin–
safranin and analysed microscopically using a Nikon Eclipse
5DI microscope connected to a Nikon DS-42-RI1 camera
(200£ or 400£ magnification) (Nikon Instruments). Tissue
samples were analysed for infiltration of immune cells,
damage in crypt architecture, hyperaemia and mucosal ero-
sion and were given a histological colitis score according to
the severity of these parameters(46). The veterinary pathologist
examining the tissue samples was blinded to treatment.
Faecal and caecal microbiota composition analysis using
quantitative PCR
Total genomic DNA from faecal samples and caecal content
samples was extracted using the FastDNA SPIN Kit for Soil
(MP Biomedicals). For the enumeration of total 16S rRNA
gene copies and nine bacterial groups prevalent in the gut
microbiota, namely Firmicutes, Bacteroides spp., Clostridium
cluster IV, F. prausnitzii, E. hallii, Enterobacteriaceae,
Lactobacillus/Leuconostoc/Pediococcus spp., Roseburia spp./
E. rectale, and sulphate-reducing bacteria (SRB), primers target-
ing the 16S rRNA gene or a functional gene were used for qPCR
carried out with an ABI PRISM 7500-PCR sequence detection
system using 2£ SYBR Green PCR Master Mix (Life
Technologies), as described previously(27,47). In short, PCR
comprising 0·2mM of each primer in 25ml volume were carried
out in duplicate for each sample. In every run, a standard curve
with serially diluted 16S rRNA gene or functional gene concen-
trations of a representative strain for each bacterial target group
was included. SRB were enumerated with the same protocol
using the primers dsrA_F336 (50-CTG CGA ATA TGC CTG
CTA CA-30) and dsrA_R533 (50-TGG TCG ARC TTG ATG TCG
TC-30) targeting the dissimilatory sulphite reductase subunit
A(48), and E. hallii 16S rRNA gene copies were evaluated
using the primers EhalF (50-GCGTAGGTGGCAGTGCAA-30)
and EhalR (50-GCACCGRAGCCTATACGG-30)(49).
Pyrosequencing analysis
Pyrosequencing analysis was carried out using caecal
samples of the control group, Fe-deficient group and
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Fig. 1. Study set-up with different iron feeding regimens according to a classical iron depletion–repletion study design. Germ-free Fischer 344 rats (n 40) were
divided into five groups and inoculated with the same microbiota from a human volunteer. After 3 weeks of initial colonisation for gut microbiota establishment,
diets differing only in iron concentration were fed to rats as outlined in the figure.
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35 ppm Fe-supplemented group for three rat pairs in each
group. Caecal content samples of the two rats housed in
the same cage were pooled, and DNA was extracted using
the FastDNA SPIN Kit for Soil (MP Biomedicals), resulting in
three genomic DNA samples per analysed group of rats
(total of nine genomic DNA samples). Pyrosequencing anal-
ysis was carried out by DNAVision (Charleroi, Belgium)
using a 454 Life Sciences Genome Sequencer FLX instrument
(Roche Applied Science), following previously described pro-
cedures(27). Resulting reads from the hypervariable gene
region V5–V6 of the 16S rRNA gene were assigned to samples
according to their multiplex identifier tag, checked for the
presence of primer sequences and fragment length .200 bp.
All reads not fulfilling these criteria were discarded, resulting
in an average number of sequences of 5345 (SD 1929) per
sample used in taxonomic assignment. Sequences were
assigned on family and genus level using the Mothur(50) and
Greengenes 16S reference database(51). Moreover, sequences
that did not align where 95 % of the other sequences aligned
were discarded. Chimera candidates were identified using
the UCHIME implementation in Mothur(52). Relative abun-
dances of unassigned reads or reads assigned on family or
genus level were calculated from the total number of reads
matching the quality control criteria.
Metabolite analysis
Caecal content samples were centrifuged (10 000g) and super-
natants were diluted with MilliQ water before analysis by
HPLC as described previously(53). Fermentative metabolites
(lactate, formate, acetate, propionate, butyrate, isovalerate,
isobutyrate and valerate) and SCFA (acetate, propionate and
butyrate) in each sample were analysed in duplicate.
Statistical analysis
Statistical analysis was carried out using JMP 8.0 and SPSS 18.0
(IBM SPSS, Inc.). All data were tested for normal distribution
using the Shapiro–Wilk test and are expressed as means
with their standard errors. Hb, ferritin, weight gain and gut
microbiota concentrations for each metabolite and caecal
qPCR data for each bacterial target were compared between
the groups of rats using one-way ANOVA with a post hoc
Bonferroni test. Diet consumption was compared using non-
parametric Kruskal–Wallis test. qPCR data on faecal micro-
biota composition were analysed over time for every bacterial
target within each rat group using one-way repeated-measures
ANOVA with Greenhouse–Geisser correction and post hoc
Bonferroni test. qPCR data were log10-transformed before
statistical analysis. Histological colitis scores and pyrosequen-
cing data were compared pairwise using the non-parametric
Mann–Whitney U test. P values ,0·05 were considered
significantly different.
Results
Iron status, faecal iron concentrations, weight gain and
diet consumption
Fe status of rats fed different Fe diets was assessed by blood
Hb concentration measurements at midpoint (week 15) and
at endpoint (week 19), while ferritin concentration was
measured at endpoint (Table 1). Although rats were fed a
highly Fe-deficient diet (2·9 mg Fe/kg diet) for up to 16 weeks
after an initial colonisation period during which they were fed
a standard diet, Hb and ferritin concentrations at endpoint
(week 19) were not significantly different between the
groups of rats. However, lighter caecal content colour and
liver colour were observed in the majority of rats in the Fe-
deficient group (Fig. S1, available online). Weight gain was
similar between all groups of rats during the first feeding
period (weeks 3–15). During the second feeding period
(weeks 15–19), rats in the control group exhibited the highest
weight gain, which was significantly higher than that in rats in
the 70 ppm Fe-supplemented group and Fe-excess group
possibly because the control group had the lowest weight at
week 15 and therefore more growth potential during the
second feeding period. Interestingly, diet consumption was
similar between the groups of rats during the first and
second feeding periods.
Table 1. Hb and ferritin concentrations, weight gain and dietary intake in rats fed a diet differing only in iron concentration at midpoint (week 15) and
endpoint (week 19) (n 7–8, each group)
(Mean values with their standard errors)
Hb week 15*
(g/l)
Hb week 19*
(g/l)
Ferritin
week 19*
(mg/l)
Weight gain
weeks 3–15*
(g)
Weight gain
weeks 15–19*
(g)
Diet consumed
weeks 3–15†
(g)
Diet consumed
weeks 15–19†
(g)
Groups Mean SEM Mean SEM Mean SEM Mean SEM Mean SEM Mean SEM Mean SEM
Control 168·9a 4·5 153·4 4·4 3·3 0·6 38·4 2·5 15·1a 1·8 716·1 11·9 262·1 5·0
Deficient 154·8a,b 4·5 147·9 2·5 1·9 0·8 37·1 2·2 9·7a,b 1·6 751·3 16·1 254·2 6·4
35 ppm Fe 150·9b 2·5 148·6 3·3 2·5 0·6 40·0 2·6 10·2a,b 1·3 747·9 12·5 273·6 3·9
70 ppm Fe 151·6b 3·1 146·9 2·5 1·7 0·4 36·6 4·2 8·7b 0·9 770·2 24·2 255·3 8·7
Fe excess 150·7b 3·8 147·1 1·6 4·4 1·4 41·0 1·3 8·9b 1·0 747·7 13·1 254·6 5·0
P 0·007 0·549 0·073 0·761 0·010 0·380 0·535
a,b Mean values within a column with unlike superscript letters were significantly different (P,0·05).
* Differences among groups were tested by ANOVA and post hoc Bonferroni test.
† Differences among groups were tested by non-parametric Kruskal–Wallis test.
A. Dostal et al.2138
B
ri
ti
sh
Jo
u
rn
al
o
f
N
u
tr
it
io
n
https:/www.cambridge.org/core/terms. https://doi.org/10.1017/S000711451400021X
Downloaded from https:/www.cambridge.org/core. University of Basel Library, on 10 Jul 2017 at 15:49:46, subject to the Cambridge Core terms of use, available at
At endpoint, Fe concentration in the faecal samples of rats
in the Fe-deficient group (20 (SEM 3) mg Fe/kg) was signi-
ficantly lower than that in the faecal samples of rats in the
35 ppm Fe-supplemented group (185 (SEM 14) mg Fe/kg,
P,0·001) and control group (184 (SEM 7) mg Fe/kg, P,0·001).
Effect of different iron concentrations in the diet on
histological colitis scores
Ileum, caecum and colon of rats were collected after killing
them, preserved in paraformaldehyde, and investigated by
light microscopy for infiltration of immune cells, damage in
crypt architecture, hyperaemia and mucosal erosion to evalu-
ate histological colitis scores (Fig. 2(a)–(c)). In general, no
severe colitis was detected in the ileum, caecum or colon
of all rat groups, and the highest average score was 4·3
(SEM 0·4) (ileum, 35 ppm Fe-supplemented group) of a maxi-
mum possible score of 11, indicating very light colitis. Rats
fed an Fe-deficient diet had the lowest ileum histological
colitis scores (score of 0·8 (SEM 0·3)), which were significantly
lower than those of the control rats (3·5 (SEM 0·4), P¼0·001)
and 35 ppm Fe-supplemented rats (4·3 (SEM 0·4), P¼0·0009)
(Fig. 2(a)). Caecum histological colitis scores were similar
between all groups of rats and rats in the 35 ppm Fe-
supplemented group had the highest scores (2·9 (SEM 0·5))
(Fig. 2(b)). Supplementation with 35 ppm Fe after feeding
an Fe-deficient diet (35 ppm Fe-supplemented group)
significantly increased the caecum histological colitis scores
compared with those of rats in the Fe-deficient group.
Surprisingly, when a diet with 70 ppm Fe was fed after feeding
an Fe-deficient diet (70 ppm Fe-supplemented group), no
increase in histological colitis scores was observed. The
opposite observation was made in the colon, wherein the
70 ppm Fe-supplemented group had higher histological colitis
scores (4·0 (SEM 0·4)) than the Fe-deficient group (Fig. 2(c)).
Moreover, differences in histological colitis scores between
the different parts of the intestine (ileum–caecum–colon)
were observed with a lower histological colitis score being
observed for the caecum in the control and 70 ppm Fe-
supplemented groups and an increase in histological colitis
scores from the ileum to the colon being observed in the
Fe-deficient group. By contrast, a significant decrease in
histological colitis scores from the ileum to the colon was
observed in rats in the 35 ppm Fe-supplemented group,
while no changes were observed in those in the Fe-
excess group.
Caecal and faecal microbiota composition in rats fed diets
differing in iron concentration
Caecal contents of all rats were collected after killing them
and the extracted DNA was investigated by qPCR to enumer-
ate different bacterial groups present in the gut microbiota
(Fig. 3) and by 454-pyrosequencing (Fig. 4(a)–(c)) to assess
gut microbiota diversity and composition. qPCR did not
reveal changes in the log number of total 16S rRNA gene
copies or Firmicutes 16S rRNA gene copies/g caecum between
the different groups of rats fed different Fe diets. The bacterial
community in all rats was dominated by Firmicutes, including
Clostridium cluster IV, followed by Bacteroides spp. (Fig. 3).
This finding was confirmed by 454-pyrosequencing in rats
in the control group, Fe-deficient group and 35 ppm
Fe-supplemented group, where the phylum Firmicutes
(54·5–82·6 %, data not shown) dominated, followed by
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Fig. 2. Histological colitis scores of (a) ileum, (b) caecum and (c) colon of
rats fed diets differing in iron concentration. Colitis scores were obtained by
light microscopy after haematoxylin/eosin/safranin staining and investigation
of infiltration of immune cells, damage in crypt architecture, hyperaemia and
mucosal erosions. Each dot represents one rat. Horizontal bars are means,
with their standard errors. * Mean value was significantly different from that of
the control group (P,0·05; non-parametric Mann–Whitney U test). † Mean
value was significantly different from that of the iron-deficient group (P,0·05;
non-parametric Mann–Whitney U test).
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Bacteroidetes (14·3–42·0 %, data not shown). On the
taxonomic family level, these rats had the highest relative
abundance (34·1–43·8 %) of Lachnospiraceae (Firmicutes)
(Fig. 4(a)).
The levels of dominant bacterial groups (Firmicutes,
Bacteroides spp. and Clostridium cluster IV) in caecum were
similar in rats in the control and Fe-deficient groups. However,
the levels of E. hallii and Enterobacteriaceae were significantly
lower in rats fed an Fe-deficient diet (8·59 (SEM 0·17) and 7·89
(SEM 0·11), respectively; mean log 16S rRNA gene copies/g
caecum) than in the control rats (9·22 (SEM 0·08) and 8·61
(SEM 0·16), respectively) (Fig. 3). Moreover, a significantly
lower abundance of Bilophila spp. (0·36 (SEM 0·11)%) and
Coprococcus spp. (0·74 (SEM 0·07)%) was observed in rats
in the Fe-deficient group than in those in the control group
(Bilophila spp., 0·87 (SEM 0·19)%; Coprococcus spp. 2·11 (SEM
0·58)%) by 454-pyrosequencing (Fig. 4(c)). Bacteroides spp.,
Clostridium cluster IV, F. prausnitzii, E. hallii and SRB were
significantly increased in the caecum of rats in the 35ppm Fe-
supplemented group than in that of rats in the Fe-deficient
group; however, bacterial concentrations did not increase to
higher levels compared with those in the control group
(Fig. 3). The 454-pyrosequencing analysis revealed a signifi-
cantly higher relative abundance of Lachnospiraceae (43·81
(SEM 2·79)%, Fe-deficient group: 34·14 (SEM 1·97)%), Rumino-
coccaceae (12·15 (SEM 1·30)%, Fe-deficient group: 8·25 (SEM
0·38)%) and Veillonellaceae (0·46 (SEM 0·05)%, Fe-deficient
group: 0·29 (SEM 0·02)%) in the 35ppm Fe-supplemented
group than in the Fe-deficient group (Fig. 4(a)). On the
genus level, the abundance of Coprococcus spp. (2·21 (SEM
0·43)%, Fe-deficient group: 0·74 (SEM 0·07)%) and Bilophila
spp. (0·77 (SEM 0·05)%, Fe-deficient group: 0·36 (SEM 0·11)%)
was significantly increased, while that of Enterococcus spp.
(0·05 (SEM 0·03)%, Fe-deficient group: 1·24 (SEM 1·03)%)
and Turicibacter spp. (0·23 (SEM 0·14)%, Fe-deficient group:
1·41 (SEM 0·38)%) was significantly decreased in the 35ppm
Fe-supplemented group than in the Fe-deficient group
(Fig. 4(b) and (c)). Bacterial populations in rats in the 70ppm
Fe-supplemented group and the Fe-excess group did not
differ when compared with those in rats in the Fe-deficient
group or control group, respectively (Fig. 3).
Faecal samples collected at baseline (week 3), midpoint
(week 15) and endpoint (week 19) shortly before killing
were analysed for microbial composition using qPCR to
enumerate prevalent bacterial groups (Table S2, available
online). During the entire trial period of 16 weeks, the
faecal microbiota was very stable, with changes in the log
numbers of 16S rRNA gene copies of dominant bacterial
groups per g faeces being less than 1 log, and no direct
correlations between dietary Fe concentrations and faecal
microbiota composition could be extracted.
Effect of different iron diets on caecal microbiota
metabolic activity
Fermentative metabolites and SCFA concentrations measured
by HPLC (Fig. 5) were not different between rats in the
Fe-deficient group and those in the control group. However,
supplementation with Fe at the 35 and 70 ppm levels
affected the caecal microbiota metabolic profile profoundly.
Fermentative metabolites and acetate and propionate concen-
trations were all significantly increased in rats in the 35 ppm
Fe-supplemented group (83·2 (SEM 10·1), 33·7 (SEM 2·3) and
15·3 (SEM 0·9) mM, respectively) and the 70 ppm Fe-
supplemented group (62·0 (SEM 2·6), 33·1 (SEM 1·6) and
14·5 (SEM 0·9) mM, respectively) than in those in the
Fe-deficient group (39·6 (SEM 1·6), 23·7 (SEM 1·2) and
9·5 (SEM 0·5) mM, respectively). Moreover, butyrate concen-
tration was significantly increased in the 35 ppm
Fe-supplemented group (29·5 (SEM 7·5) mM) compared with
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the Fe-deficient group (4·8 (SEM 0·8) mM). Propionate and
butyrate concentrations in the 35 ppm Fe-supplemented
group were even higher than those in the control group. On
the other hand, supplementation with 70 ppm Fe led to no sig-
nificant increase in butyrate concentration compared with that
in rats in the Fe-deficient group. Propionate (15·4 (SEM
0·7) mM) and butyrate (16·7 (SEM 3·9) mM) concentrations
were significantly increased in the Fe-excess group compared
with the control group (11·7 (SEM 0·8) and 3·3 (SEM 0·6) mM,
respectively).
Discussion
The results of the present study carried out using human gut
microbiota-associated rats provide a new insight into the
highly complex interactions between the host, the gut micro-
biota and Fe. Colonisation of rats with human gut microbiota
was successful, and dominant bacterial groups were present
at similar levels in rats at baseline and in the donor microbiota
as described previously(36,40). The use of one faecal donor also
led to highly similar microbiotas in all rats, whereas in humans
variability in microbiota composition between individuals is
high and may potentially mask smaller effects(54). Feeding
regimens were set up according to the classical Fe
depletion–repletion study(42) in which Fe depletion is started
in very young rats (usually 3 weeks old), which have small
body Fe stores and high Fe needs for growth, leading to
severe Fe-deficiency anaemia(28,42).
Surprisingly, in the present study, the 12- and 16-week
depletion periods were insufficient to induce Fe-deficiency
anaemia. This may be because the rats were 8 weeks of age
when the intervention was started (instead of the usual
3 weeks) and had time to build up adequate Fe stores. Drawing
on these stores allowed them to maintain Hb concentrations
during the depletion period. However, rats in the Fe-deficient
group had caecal contents of a lighter colour, suggesting a
mild degree of Fe depletion (Fig. S1, available online). In
addition, Fischer 344 rats are known to be more resistant to
Fe deficiency than the Sprague–Dawley rats usually used in a
Hb depletion–repletion study(55). At endpoint, faecal Fe con-
centrations in rats were higher than dietary Fe concentrations,
which may be explained by a concentration effect of Fe in
the gut lumen during water and nutrient absorption and a poss-
ible Fe loss in the host by sloughed enterocytes.
Dietary Fe supplementation has been shown to be
associated with increased inflammatory reactions of the gut
mucosa possibly generated by the production of reactive
oxygen species in the presence of elevated luminal Fe
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concentration, which has been observed in inflammatory
bowel disease patients and rat models(56–58), while other
studies suggest an involvement of gut bacterial composition
changes due to Fe concentrations(25,59). Werner et al.(25)
found that a low-Fe diet completely inhibited gut inflam-
mation in a mouse colitis model, while Fe supplementation
in wild-type mice had no effect on colitis scores. In agreement,
the present study showed lower histological colitis scores of
ileum and colon in rats fed an Fe-deficient diet while Fe sup-
plementation with 35 ppm Fe but not with 70 ppm Fe caused
light colitis in ileum and caecum. Therefore, no clear inflam-
mation pattern related to Fe concentrations could be detected
in the investigated rats. Fe supplementation in school children
in Coˆte d’Ivoire has been found to clearly increase calprotectin
concentrations, but in an environment with a high risk of
pathogen exposure(30). We speculate that Fe supplementation
in the range of physiological levels may not lead to mucosal
inflammation unless other influencing factors are present
such as a high contamination with pathogens or an inflamma-
tory pre-set of the host.
Faecal microbiota composition in all rats was very stable
over time. Because rats had normal Fe status, we speculated
that especially under an Fe-deficient diet regimen, bacteria
in the colon could sequester Fe from sloughed enterocytes.
Therefore, caecal contents were analysed, in which Fe might
have a more direct impact on the microbiota. There was no
difference in gut microbiota metabolic activity in caecum
between rats in the Fe-deficient group and those in the control
group. However, we found that low luminal Fe concentrations
slightly affected the gut microbiota composition and
decreased the relative abundances of Bilophila spp., E. hallii
and Coprococcus spp. most probably due to Fe-dependent
enzymes such as hydrogenases in their metabolic
pathways(9,60,61).
The findings of the present study are in contrast to previous
findings in highly Fe-deficient rats and also to the results of an
in vitro colonic fermentation experiment(24,27). In both exper-
iments, very-low-Fe conditions had caused major dysbiosis of
the gut microbiota and especially decreased butyrate and pro-
pionate production. Moreover, it has been shown that changes
in host Fe metabolism in mice and humans have effects on
the gut microbiota without changing dietary Fe concen-
trations(32,62). However, in the present study, hosts were not
Fe deficient and it is possible that host Fe plays an important
role in the maintenance of the composition and metabolic
function of the gut microbiota as part of the symbiosis
between the microbiota and the host. Indeed, during low-Fe
diet feeding, faecal Fe concentrations were 20 mg Fe/kg
faeces, which could be provided by unabsorbed dietary Fe
and by sloughed enterocytes from the host. These faecal Fe
concentrations are probably adequate to maintain the gut
microbiota as has been shown in our previous in vitro
studies(27).
Fe supplementation with 35 mg Fe/kg diet from FeSO4
(35 ppm Fe-supplemented group) had a strong effect on
both the caecal microbiota composition and metabolic
activity, especially increasing the abundance of Bacteroides
spp. and butyrate producers such as Clostridium cluster IV
members, e.g. F. prausnitzii, and Coprococcus spp. Moreover,
a decrease in the relative abundances of Turicibacter spp. and
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Enterococcus spp., both of which are opportunistic patho-
gens(63,64), was observed during feeding of the 35 ppm Fe
diet than during feeding of a Fe-deficient diet. Enterococci
most probably had a growth advantage under low-Fe con-
ditions due to their restricted need for Fe and lost this
advantage during Fe supplementation. Similar observations
were made in mice in which feeding a diet containing Fe
led to an increase in the abundance of Bacteroides spp. and
to a decrease in that of Turicibacter spp. compared with
feeding a Fe-free diet(25).
The concentrations of acetate, propionate and especially
butyrate were significantly increased due to Fe supplemen-
tation compared with those in rats in the Fe-deficient group.
In a previous study, Fe supplementation has been found to
lead to a significant increase in butyrate and propionate
concentrations in highly Fe-deficient rats(24). Moreover,
Fe-deficient conditions in the same rat study and also in a
colonic in vitro fermentation study led to a decrease in buty-
rate and propionate production(27). These observations
suggest that Fe is a crucial element for butyrate and propio-
nate production in strict anaerobic gut bacteria. Indeed, in
the butyrate production pathway, oxidoreductases and
hydrogenases are involved(8,14,65), which are often Fe depen-
dent, and under conditions of optimal bioavailable Fe concen-
trations, the conversion of dietary or host carbons into end
metabolites such as butyrate by gut bacteria may be enhanced.
Studies in bioreactors with mixed strict-anaerobe cultures have
shown that increasing Fe concentrations lead to a higher H2
and butyrate yield per carbon source(29,66,67). Indeed, when
calculating the total carbon output from bacterial fermentation
in the form of SCFA, the diet with 35 mg Fe/kg diet from FeSO4
(35 ppm Fe-supplemented group) led to more than double the
carbon output than the control diet or a Fe-deficient diet,
mainly due to the promotion of butyrate production, although
diet consumption was similar in these groups of rats. SCFA can
provide up to an additional 10 % of daily dietary energy to the
host from indigestible compounds, such as fibres(68). This pro-
motion of carbon output due to Fe supplementation could
increase the energy source of plant-based diets, which are
mainly consumed in developing countries, and therefore
might contribute to weight gain in malnourished individuals.
A significant increase in caecal butyrate and propionate con-
centrations along with a decrease in the abundance of possible
opportunistic pathogens due to 35ppm Fe supplementation
could lead to beneficial effects on host gut health. Propionate
produced by several Bacteroides spp. has been shown to be
involved in the regulation of satiety(69). Butyrate is the main
energy source for colonocytes, and it can inhibit NF-kB acti-
vation and therefore decrease inflammatory responses(70,71).
Moreover, butyrate has anti-carcinogenic effects through the
promotion of apoptosis and inhibition of proliferation(72).
Interestingly, no correlation between increased butyrate con-
centrations and decreased colitis scores was observed in the
present study, but the anti-inflammatory effects of butyrate
might be much more visible in mucosa with an inflammatory
pre-set. Moreover, the abundance of H2-utilising and potentially
toxic H2S-producing SRB was increased with Fe supplemen-
tation in the present study possibly due to the promotion of
the production of H2, a by-product of the butyrate production
pathway(65). SRB have been identified as possible contributors
of different digestive pathologies such as inflammatory bowel
syndrome and inflammatory bowel disease(40,73–76), and H2S
has been shown to affect metabolic functions in colonocytes
and to cause DNA damage(74,76). However, other studies have
suggested a protective role of H2S in the epithelial layer
during inflammation and identified H2S as an important
mediator for intracellular processes(77,78). Therefore, it remains
difficult to directly associate an increase in SRB counts and
H2S production with negative effects on the gut mucosa, and
no negative modulation of the gut mucosa could be detected
in the present study.
In conclusion, the present study carried out using human
gut microbiota-associated rats investigated the effects of diet-
ary Fe concentrations on the gut microbiota. Our data suggest
that an Fe-deficient diet alone may have no major effects on
dominant bacterial populations or gut microbiota metabolic
activity in a host, which is not Fe deficient based on blood
parameters as observed in the study. By contrast, Fe sup-
plementation with 35 mg Fe/kg diet from FeSO4 promoted
dominant bacterial groups and slightly increased SRB, while
the abundance of potential opportunistic pathogens was
decreased. Moreover, Fe supplementation strongly increased
the metabolic activity of the gut microbiota. Histological colitis
scores remained very low despite Fe supplementation, indicat-
ing that Fe alone does not lead to gut inflammation. Thus,
we suggest that Fe supplementation might confer additional
health benefits on the host by stimulating the gut microbiota
without an inflammatory gut mucosa and in a relatively
pathogen-free environment.
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